Sort
261,768 grants matching “gene therapy”
Cardiac lineage determination and nuclear architecture
$957,952Jonathan A Epstein · University Of Pennsylvania · R35 · FY2019 · HL
Cardiac lineage determination and nuclear architecture
$957,952Jonathan A Epstein · University Of Pennsylvania · R35 · FY2020 · HL
Cardiac lineage determination and nuclear architecture
$957,952Jonathan A Epstein · University Of Pennsylvania · R35 · FY2023 · HL
2-HOBA for Treatment of Pulmonary Hypertension
$957,913John A Rathmacher · Mti Biotech, Inc. · R42 · FY2025 · HL
2-HOBA for Treatment of Pulmonary Hypertension
$957,913John A Rathmacher · Mti Biotech, Inc. · R42 · FY2024 · HL
Transgenic T cell Therapy for Acute Myeloid Leukemia
$957,908Aude Chapuis · Fred Hutchinson Cancer Center · P01 · FY2025 · CA
Transgenic T cell Therapy for Acute Myeloid Leukemia
$957,908Aude Chapuis · Fred Hutchinson Cancer Center · P01 · FY2024 · CA
Role of inflammation, innate resistance, and immunity in carcinogenesis
$957,864Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Commercialization of PANDAA qDx for rapid drug resistance genotyping of protease inhibitor ART failures in resource-limited settings.
$957,844Iain James Macleod · Aldatu Biosciences, Inc. · SB1 · FY2024 · AI
Red Cell Biology
$957,817David M. Bodine · National Human Genome Research Institute · ZIA · FY2018 · HG
Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity
$957,734Lisa Tussing-Humphreys · University Of Illinois At Chicago · R01 · FY2025 · CA
Kinase Targeted Antimalarial Agents
$957,654Reena Zutshi · Luceome Biotechnologies, Llc · R44 · FY2020 · AI
Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome
$957,638Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
A Randomized Phase 2A Clinical Trial Pioneering the Utility of an eNAMPT-Reducing Therapy in ARDS/VILI: the PUERTA Trial
$957,594Joe G. N. Garcia · Aqualung Therapeutics Corp. · R44 · FY2024 · HL
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$957,460Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Determining the Fate of Transmembrane Proteins
$957,415Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Targeted therapies for Kaposi sarcoma and KSHV-multicentric Castleman disease
$957,389Ramya Ramaswami · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
CENTER FOR CEREBROVASCULAR DISEASE
$957,351Stanford University · P01 · FY2003 · NS
Predicting Cancer Cell Response to Endogenous and Exogenous Perturbations at the Single Cell Level
$957,321Andrea Califano · Columbia University Health Sciences · R35 · FY2023 · CA
An integrated genotyping approach for HLA and other genetic systems
$957,318Wyatt Nelson · Scisio Genetics, Inc. · R44 · FY2015 · AI
Longitudinal Cognitive ERP studies: Advancement for AD Clinical Trials
$957,278John M Olichney · University Of California At Davis · R01 · FY2016 · AG
Refanalin for lung preservation and transplantation
$957,162Weizhong Cai · Angion Biomedica Corporation · R44 · FY2008 · HL
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies
$957,084Anne E Chiaramello · George Washington University · UH3 · FY2023 · TR
Metabolic Networks and Pathways in Alzheimer's Disease
$957,041Rima F Kaddurah-Daouk · Duke University · R01 · FY2015 · AG
Cell and Cancer Biology Branch Confocal Microscopy Core
$957,040Yvona Ward · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA